Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Skp2: a novel potential therapeutic target for prostate cancer.

Skp2: a novel potential therapeutic target for prostate cancer. Biochim Biophys Acta. 2012 Jan; 1825(1):11-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.